Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Dietary intake and nutritional status in patients with systemic lupus erythematosus.

Pocovi-Gerardino G, Correa-Rodríguez M, Callejas-Rubio JL, Ríos-Fernández R, Ortego-Centeno N, Rueda-Medina B.

Endocrinol Diabetes Nutr. 2018 Nov;65(9):533-539. doi: 10.1016/j.endinu.2018.05.009. Epub 2018 Jul 8. English, Spanish.

PMID:
29997049
2.

Venous thrombosis and relapses in patients with Behçet's disease. Descriptive analysis from Spanish network of Behçet's disease (REGEB cohort).

Rodríguez-Carballeira M, Solans R, Larrañaga JR, García-Hernández FJ, Rios-Fernández R, Nieto J, Solanich X, Martínez-Valle F, Fonseca E, Muñoz FJ, Fraile G, de Escalante B, Boldova R, Hurtado R, Espinosa G; REGEB investigators, Autoimmune Diseases Study Group (GEAS).

Clin Exp Rheumatol. 2018 May 3. [Epub ahead of print]

PMID:
29745871
3.

Facts in treatment of pulmonary arterial hypertension associated to mixed connective tissue disease.

Callejas Rubio JL, Ríos Fernández R, Ortego Centeno N.

Med Clin (Barc). 2018 Apr 20. pii: S0025-7753(18)30168-4. doi: 10.1016/j.medcli.2018.02.026. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29685309
4.

Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.

Sánchez-Cano D, Ortego-Centeno N, Callejas JL, Fonollosa Plá V, Ríos-Fernández R, Tolosa-Vilella C, Espinosa-Garriga G, Colunga-Argüelles D, Egurbide-Arberas MV, Rubio-Rivas M, Freire M, Ríos-Blanco JJ, Trapiella-Martínez L, Rodríguez-Carballeira M, Marín-Ballvé A, Pla-Salas X, Simeón-Aznar CP.

Rheumatol Int. 2018 Mar;38(3):363-374. doi: 10.1007/s00296-017-3916-x. Epub 2018 Jan 10.

PMID:
29322341
5.

Low-Dose Rituximab for Hemolytic Anemia Retreatment in a Patient With Systemic Lupus Erythematosus.

Rios-Fernández R, Callejas-Rubio JL, Sánchez-Cano D, Ortego-Centeno N.

Am J Ther. 2018 Sep/Oct;25(5):e577-e578. doi: 10.1097/MJT.0000000000000658. No abstract available.

PMID:
29232288
6.

Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross-sectional study.

Manzano-Gamero V, Pardo-Cabello AJ, Vargas-Hitos JA, Zamora-Pasadas M, Navarrete-Navarrete N, Sabio JM, Jáimez-Gámiz L, Ríos-Fernandez R, Ortego-Centeno N, Ayala-Gutierrez MM, de Ramón E, Colodro-Ruíz A, Micó-Giner L, Castillo-Palma MJ, Robles-Marhuenda Á, Luna-Del Castillo JD, Jiménez-Alonso J; Spanish Autoimmune Diseases Study Group (GEAS).

Int J Rheum Dis. 2017 Jun 7. doi: 10.1111/1756-185X.13117. [Epub ahead of print]

PMID:
28593703
7.

Subclinical arteriosclerosis and osteoprotegerin levels in a population with systemic lupus erythematous in the south of Europe.

López-Robles C, Rios-Fernández R, Callejas-Rubio JL, Moreno-Escobar E, Martín-DeLaFuente P, Ortego-Centeno N.

Lupus. 2016 Jun;25(7):781-2. doi: 10.1177/0961203315624556. Epub 2016 Jan 13. No abstract available.

PMID:
26768749
8.

[Usefulness of assessment of antinuclear antibodies in pleural effusion for diagnosis of lupus pleuritis].

Callejas Rubio JL, Ríos Fernández R, Moreno Higueras M, Ortego Centeno N.

Med Clin (Barc). 2016 Apr 1;146(7):e37. doi: 10.1016/j.medcli.2015.10.034. Epub 2015 Dec 23. Spanish. No abstract available.

PMID:
26723940
9.

Low bone mass and carotid atherosclerosis in lupus erythematosus patients from Granada, a city in the south of Spain.

López-Robles C, Ríos-Fernández R, Callejas-Rubio JL, Moreno-Escobar E, Ortego-Centeno N.

Lupus. 2016 Feb;25(2):223-4. doi: 10.1177/0961203315608255. Epub 2015 Sep 29. No abstract available.

PMID:
26424129
10.

Antiphospholipid syndrome, antiphospholipid antibodies and solid organ transplantation.

González-Moreno J, Callejas-Rubio JL, Ríos-Fernández R, Ortego-Centeno N.

Lupus. 2015 Nov;24(13):1356-63. doi: 10.1177/0961203315595129. Epub 2015 Jul 9. Review.

PMID:
26162685
11.

Oral Calcidiol Is More Effective Than Cholecalciferol Supplementation to Reach Adequate 25(OH)D Levels in Patients with Autoimmune Diseases Chronically Treated with Low Doses of Glucocorticoids: A "Real-Life" Study.

Ortego-Jurado M, Callejas-Rubio JL, Ríos-Fernández R, González-Moreno J, González Ramírez AR, González-Gay MA, Ortego-Centeno N.

J Osteoporos. 2015;2015:729451. doi: 10.1155/2015/729451. Epub 2015 Jun 1.

12.

Pulmonary Langerhans Histiocytosis: an uncommon cause of interstitial pneumonia in a patient with Sjögren syndrome.

González García A, Callejas Rubio JL, Ríos Fernández R, Ortego Centeno N.

Clin Rheumatol. 2016 Mar;35(3):825-8. doi: 10.1007/s10067-015-2924-z. Epub 2015 Apr 19.

PMID:
25894436
13.

Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis.

Rios-Fernández R, Callejas-Rubio JL, García-Rodríguez S, Sancho J, Zubiaur M, Ortego-Centeno N.

Am J Ther. 2016 Sep-Oct;23(5):e1193-6. doi: 10.1097/MJT.0000000000000035.

PMID:
25768375
14.

Mesenteric Inflammatory Venoocclusive Disease in a Patient with Sjögren's Syndrome.

Rios-Fernández R, Callejas-Rubio JL, Caba-Molina M, Ríos-Peregrina R, Ortego-Centeno N.

Case Rep Med. 2014;2014:423420. doi: 10.1155/2014/423420. Epub 2014 Nov 16.

15.

Refractory subacute cutaneous lupus erythematous responding to a single course of belimumab: a new anti-BLyS human monoclonal antibody.

Husein-ElAhmed H, Callejas-Rubio JL, Rios-Fernandez R, Ortego-Centeno N.

Indian J Dermatol Venereol Leprol. 2014 Sep-Oct;80(5):477-8. doi: 10.4103/0378-6323.140335. No abstract available.

16.

Pyoderma gangrenosum and systemic lupus erythematosus: a report of five cases and review of the literature.

González-Moreno J, Ruíz-Ruigomez M, Callejas Rubio JL, Ríos Fernández R, Ortego Centeno N.

Lupus. 2015 Feb;24(2):130-7. doi: 10.1177/0961203314550227. Epub 2014 Sep 8. Review.

PMID:
25199808
17.

Vitamin D levels and response to biphosphonates in postmenopausal women receiving glucocorticoid therapy.

Ortego-Jurado M, Ríos-Fernández R, Callejas-Rubio JL, Gonzalez-Gay MA, Ortego-Centeno N.

Osteoporos Int. 2014 Aug;25(8):2157-8. doi: 10.1007/s00198-014-2713-6. Epub 2014 May 7. No abstract available.

PMID:
24803328
18.

Registry of the Spanish network of Behçet's disease: a descriptive analysis of 496 patients.

Rodríguez-Carballeira M, Alba MA, Solans-Laqué R, Castillo MJ, Ríos-Fernández R, Larrañaga JR, Martínez-Berriotxoa A, Espinosa G; REGEB investigators.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S33-9. Epub 2014 Jan 30.

PMID:
24480539
19.

Health-related internet use by lupus patients in southern Spain.

Callejas-Rubio JL, Ríos-Fernández R, Barnosi-Marín AC, García-Hernández FJ, Vargas-Hitos JA, Camps-García MT, González-Nieto JA, Sánchez-Román J, Jiménez-Alonso J, de Ramón Garrido E, Ortego-Centeno N.

Clin Rheumatol. 2014 Apr;33(4):567-73. doi: 10.1007/s10067-013-2395-z. Epub 2013 Oct 6. Erratum in: Clin Rheumatol. 2014 Apr;33(4):575. Otego-Centeno, Norberto [corrected to Ortego-Centeno, Norberto].

PMID:
24096638
20.

Health-related Internet use by patients with systemic sclerosis and other autoimmune diseases: comment on the article by van der Vaart et al.

Ortego-Centeno N, Callejas-Rubio JL, Ríos-Fernández R, Simeón-Aznar CP.

Arthritis Care Res (Hoboken). 2014 Feb;66(2):334. doi: 10.1002/acr.22157. No abstract available.

21.

Off-label uses of anti-TNF therapy in three frequent disorders: Behçet's disease, sarcoidosis, and noninfectious uveitis.

Sánchez-Cano D, Callejas-Rubio JL, Ruiz-Villaverde R, Ríos-Fernández R, Ortego-Centeno N.

Mediators Inflamm. 2013;2013:286857. doi: 10.1155/2013/286857. Epub 2013 Aug 1. Review.

22.

Impaired sexual function in women with systemic lupus erythematosus: a cross-sectional study.

García Morales M, Callejas Rubio JI, Peralta-Ramírez MI, Henares Romero LJ, Ríos Fernández R, Camps García MT, Navarrete Navarrete N, Ortego Centeno N.

Lupus. 2013 Sep;22(10):987-95. doi: 10.1177/0961203313500370.

PMID:
23963430
23.

IL2/IL21 region polymorphism influences response to rituximab in systemic lupus erythematosus patients.

Márquez A, Dávila-Fajardo CL, Robledo G, Rubio JL, de Ramón Garrido E, García-Hernández FJ, González-León R, Ríos-Fernández R, Barrera JC, González-Escribano MF, García MT, Palma MJ, del Mar Ayala M, Ortego-Centeno N, Martín J.

Mol Biol Rep. 2013 Aug;40(8):4851-6. doi: 10.1007/s11033-013-2583-6. Epub 2013 May 5.

PMID:
23645042
24.

Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patients.

Garcia-Rodriguez S, Callejas-Rubio JL, Ortego-Centeno N, Zumaquero E, Ríos-Fernandez R, Arias-Santiago S, Navarro P, Sancho J, Zubiaur M.

Mediators Inflamm. 2012;2012:495934. doi: 10.1155/2012/495934. Epub 2012 Oct 18.

25.

Association of the FCGR3A-158F/V gene polymorphism with the response to rituximab treatment in Spanish systemic autoimmune disease patients.

Robledo G, Márquez A, Dávila-Fajardo CL, Ortego-Centeno N, Rubio JL, Garrido Ede R, Sánchez-Román J, García-Hernández FJ, Ríos-Fernández R, González-Escribano MF, García MT, Palma MJ, Ayala Mdel M, Martín J.

DNA Cell Biol. 2012 Dec;31(12):1671-7. doi: 10.1089/dna.2012.1799. Epub 2012 Oct 17.

PMID:
23075294
26.

Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions.

Rios-Fernández R, Callejas-Rubio JL, Fernández-Roldán C, Simeón-Aznar CP, García-Hernández F, Castillo-García MJ, Fonollosa Pla V, Barnosi Marín AC, González-Gay MÁ, Ortego-Centeno N.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):905-11. Epub 2012 Dec 17.

PMID:
22935485
27.

No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis.

Cénit MC, Simeón CP, Fonollosa V, Espinosa G, Beltrán E, Sáez-Comet L, Vicente-Rabaneda E, García-Hernández FJ, Martínez-Estupiñán L, Rodríguez-Carballeira M, Hernández V, de la Peña PG, Fernández-Castro M, Narváez FJ, Pros A, Gallego M, Ríos-Fernández R, Camps MT, Fernández-Nebro A, Egurbide MV, Carreira P, González-Gay MA, Martín J; Spanish Scleroderma Group.

Tissue Antigens. 2012 Sep;80(3):254-8. doi: 10.1111/j.1399-0039.2012.01915.x. Epub 2012 Jun 29.

PMID:
22742541
28.

Association between -174 interleukin-6 gene polymorphism and biological response to rituximab in several systemic autoimmune diseases.

Robledo G, Dávila-Fajardo CL, Márquez A, Ortego-Centeno N, Callejas Rubio JL, de Ramón Garrido E, Sánchez-Román J, García-Hernández FJ, Ríos-Fernández R, González-Escribano MF, Camps García MT, Castillo Palma MJ, Ayala Mdel M, Martín J.

DNA Cell Biol. 2012 Sep;31(9):1486-91. doi: 10.1089/dna.2012.1684. Epub 2012 Jun 26.

PMID:
22734797
29.

Adalimumab for the treatment of Behçet's disease: experience in 19 patients.

Perra D, Alba MA, Callejas JL, Mesquida M, Ríos-Fernández R, Adán A, Ortego N, Cervera R, Espinosa G.

Rheumatology (Oxford). 2012 Oct;51(10):1825-31. Epub 2012 Jun 20.

PMID:
22723596
30.

A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis.

Bossini-Castillo L, Simeon CP, Beretta L, Broen JC, Vonk MC, Ríos-Fernández R, Espinosa G, Carreira P, Camps MT, Castillo MJ, González-Gay MA, Beltrán E, Carmen Freire Md, Narváez J, Tolosa C, Witte T, Kreuter A, Schuerwegh AJ, Hoffmann-Vold AM, Hesselstrand R, Lunardi C, van Laar JM, Chee MM, Herrick A, Koeleman BP, Denton CP, Fonseca C, Radstake TR, Martin J; Spanish Scleroderma Group.

Arthritis Res Ther. 2012 Apr 24;14(2):R85.

31.

Otolaryngologic manifestations of systemic vasculitis.

Parra-García GD, Callejas-Rubio JL, Ríos-Fernández R, Sainz-Quevedo M, Ortego-Centeno N.

Acta Otorrinolaringol Esp. 2012 Jul-Aug;63(4):303-10. Epub 2011 Dec 15. Review. English, Spanish.

32.

Analysis of Class II human leucocyte antigens in Italian and Spanish systemic sclerosis.

Beretta L, Rueda B, Marchini M, Santaniello A, Simeón CP, Fonollosa V, Caronni M, Rios-Fernandez R, Carreira P, Rodriguez-Rodriguez L; Spanish Systemic Sclerosis Group, Moreno A, López-Nevot MA, Escalera A, González-Escribano MF, Martin J, Scorza R.

Rheumatology (Oxford). 2012 Jan;51(1):52-9. doi: 10.1093/rheumatology/ker335. Epub 2011 Nov 15.

33.

The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.

Martin JE, Carmona FD, Broen JC, Simeón CP, Vonk MC, Carreira P, Ríos-Fernández R, Espinosa G, Vicente-Rabaneda E, Tolosa C, García-Hernández FJ, Castellví I, Fonollosa V, González-Gay MA, Sáez-Comet L, Portales RG, de la Peña PG, Fernández-Castro M, Díaz B, Martínez-Estupiñán L, Coenen M, Voskuyl AE, Schuerwegh AJ, Vanthuyne M, Houssiau F, Smith V, de Keyser F, De Langhe E, Riemekasten G, Witte T, Hunzelmann N, Kreuter A, Palm Ø, Chee MM, van Laar JM, Denton C, Herrick A, Worthington J, Koeleman BP, Radstake TR, Fonseca C, Martín J; Spanish Scleroderma Group.

Genes Immun. 2012 Feb;13(2):191-6. doi: 10.1038/gene.2011.72. Epub 2011 Oct 20.

PMID:
22012429
34.

No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis.

Carmona FD, Serrano-Lopera A, López-Isac E, Simeón CP, Carreira P, Rios-Fernandez R, Espinosa G, Camps MT, Navarrete N, González-Escribano MF, Vicente-Rabaneda E, Rodríguez-Rodríguez L, Tolosa C, Beltrán E, Gómez-Garcia I, Fernández-Castro M, López-Longo FJ, García-Hernández FJ, Castellví I, Trapiella L, Fernández-Nebro A, García-Portales R, Egurbide MV, Fonollosa V, García de la Peña P, Pros A, Rodríguez-Carballeira M, Díaz-Gónzalez F, Sáez-Comet L, González-Gay MA, Martín J.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5):895-6. Epub 2011 Oct 31. No abstract available.

PMID:
22011385
35.

[Prophylactic treatment with rituximab in thrombotic thrombocytopenic purpura].

Callejas Rubio JL, Moreno Higueras M, Ríos Fernández R, Ortego Centeno N.

Med Clin (Barc). 2012 Feb 25;138(4):181; author reply 181-2. doi: 10.1016/j.medcli.2011.05.024. Epub 2011 Sep 21. Spanish. No abstract available.

PMID:
21940014
36.

Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis.

Carmona FD, Simeon CP, Beretta L, Carreira P, Vonk MC, Ríos-Fernández R, Espinosa G, Navarrete N, Vicente-Rabaneda E, Rodríguez-Rodríguez L, Tolosa C, García-Hernández FJ, Castellví I, Egurbide MV, Fonollosa V, González-Gay MA, Rodríguez-Carballeira M, Díaz-Gónzalez F, Sáez-Comet L, Hesselstrand R, Riemekasten G, Witte T, Voskuyl AE, Schuerwegh AJ, Madhok R, Shiels P, Fonseca C, Denton C, Nordin A, Palm Ø, Hoffmann-Vold AM, Airó P, Scorza R, Lunardi C, van Laar JM, Hunzelmann N, Kreuter A, Herrick A, Worthington J, Koeleman BP, Radstake TR, Martín J.

Ann Rheum Dis. 2011 Nov;70(11):2050-2. doi: 10.1136/ard.2010.148874. Epub 2011 May 13. No abstract available.

PMID:
21571730
37.

Role of the CCR5/Δ32CCR5 polymorphism in biopsy-proven giant cell arteritis.

Carmona FD, Rodríguez-Rodríguez L, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Marí-Alfonso B, Unzurrunzaga A, Ríos-Fernández R, Blanco R, de Miguel E, Martín J, González-Gay MA.

Hum Immunol. 2011 May;72(5):458-61. doi: 10.1016/j.humimm.2011.02.009. Epub 2011 Feb 25.

PMID:
21354457
38.

Role of rs1343151 IL23R and rs3790567 IL12RB2 polymorphisms in biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Marí-Alfonso B, Gómez-Vaquero C, Amigo-Díaz E, Ríos-Fernández R, Blanco R, Llorca J, Fernández-Gutiérrez B, Martín J, González-Gay MA.

J Rheumatol. 2011 May;38(5):889-92. doi: 10.3899/jrheum.101046. Epub 2011 Feb 1.

PMID:
21285166
39.

Effectiveness of mycophenolic acid in refractory pyoderma gangrenosum.

Husein-ElAhmed H, Callejas-Rubio JL, Ríos Fernandez R, Ortego Centeno N.

J Clin Rheumatol. 2010 Oct;16(7):346-7. doi: 10.1097/RHU.0b013e3181f6059f. No abstract available.

PMID:
20859217
40.

Vitamin D deficiency in a cohort of patients with systemic lupus erythematous from the South of Spain.

López-Robles C, Rios-Fernández R, Callejas-Rubio JL, Ortego-Centeno N.

Lupus. 2011 Mar;20(3):330-1. doi: 10.1177/0961203310378670. Epub 2010 Aug 19. No abstract available.

PMID:
20724350
41.

Severe Raynaud syndrome induced by adjuvant interferon alfa in metastatic melanoma.

Husein-Elahmed H, Callejas-Rubio JL, Ortega Del Olmo R, Ríos-Fernandez R, Ortego-Centeno N.

Curr Oncol. 2010 Aug;17(4):122-3.

42.

Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain.

Rios Fernández R, Fernández Roldán C, Callejas Rubio JL, Ortego Centeno N.

J Rheumatol. 2010 Jun;37(6):1355; author reply 1356. doi: 10.3899/jrheum.091143. No abstract available.

PMID:
20516041
43.

Long-term evolution of cytophagic histiocytic panniculitis.

Rios Fernández R, Callejas Rubio JL, Sánchez Cano D, Dominguez Vicent JR, Linares Solano J, Ortego Centeno N.

J Cutan Med Surg. 2010 May-Jun;14(3):136-40.

PMID:
20487674
44.

Rituximab in the treatment of dermatomyositis and other inflammatory myopathies. A report of 4 cases and review of the literature.

Rios Fernández R, Callejas Rubio JL, Sánchez Cano D, Sáez Moreno JA, Ortego Centeno N.

Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1009-16. Review.

PMID:
20149324
45.

Tongue infarction as first symptom of temporal arteritis.

Husein-Elahmed H, Callejas-Rubio JL, Rios-Fernández R, Ortego-Centeno N.

Rheumatol Int. 2012 Mar;32(3):799-800. doi: 10.1007/s00296-009-1355-z. Epub 2010 Jan 8.

PMID:
20058010
46.

Efalizumab for subacute cutaneous lupus: report of two different outcomes.

Sánchez-Cano D, Callejas-Rubio JL, Ríos-Fernández R, Gutiérrez-Salmerón MT, Fernández Pugnaire MA, Ortego-Centeno N.

Lupus. 2009 Dec;18(14):1334-6. doi: 10.1177/0961203309106761. Epub 2009 Oct 30. No abstract available.

PMID:
19880554
47.

[Adalimumab in the treatment of erythema nudosum].

Callejas Rubio JL, Ríos Fernández R, Sánchez Cano D, Ortego Centeno N.

Med Clin (Barc). 2010 Jun 12;135(2):90. doi: 10.1016/j.medcli.2009.03.028. Epub 2009 Jun 2. Spanish. No abstract available.

PMID:
19493543
48.

[Treatment of Behçet's disease with adalimumab].

Callejas-Rubio JL, Sánchez-Cano D, Ríos-Férnandez R, Ortego-Centeno N.

Med Clin (Barc). 2008 Oct 4;131(11):438-9. Spanish. No abstract available.

PMID:
18928730
49.

[Necrotizing systemic sarcoidosis with pulmonary and central nervous system involvement].

Ríos Fernández R, Callejas-Rubio JL, Guerrero Fernández M, Serrano Falcón MM, Ortego-Centeno N.

An Med Interna. 2008 Jan;25(1):23-6. Spanish.

PMID:
18377191
50.

[Paniculitis, polyarthritis and pancreatitis].

Ríos-Fernández R, Callejas-Rubio JL, Sánchez-Cano D, Martín-Ruiz JL, Ortego-Centeno N.

Rev Clin Esp. 2008 Mar;208(3):156-7. Spanish. No abstract available.

PMID:
18275770

Supplemental Content

Loading ...
Support Center